Seven reasons your ADHD medication isn't working. Jonathan Murphy, PMHNP-BC, walks through the clinical patterns that show up when adult ADHD medication fails to deliver the expected response — and what each pattern actually points toward.

This episode covers:

• Why daily consistency matters more than the cultural narrative around "as needed" stimulant use
• Why ADHD is a disorder of inconsistency and how consistent medication produces a different person over time
• The diagnostic question hiding underneath medication non-response: do you actually have ADHD
• The OCPD distinction — patients who don't fluctuate in attention but instead narrow their perception of what's possible
• Why patients with primary ADHD plus secondary anxiety often confuse the two and reach for the wrong primary treatment
• The honeymoon period of stimulant response and why a sudden three-day drop signals underlying depression
• Why immediate-release tablets can't deliver consistent symptom control and what the spike-and-crash actually represents pharmacokinetically
• The undertreatment pattern: 5-10 milligram Adderall starting doses from prescribers uncomfortable with adult ADHD medication
• The 50/50 split between adults who respond best to methylphenidate versus amphetamine
• Why hunting down a specific generic manufacturer creates more problems than it solves
• The Reddit r/ADHD ideology breakdown: how tribal identity formation distorts clinical reasoning around ADHD treatment
• The three components of online ADHD tribal narrative: the idea (our brains are different), the sentiment (it's not fair nobody noticed), the custom (complaint without accountability)
• Why the podcast operates with less filter than the YouTube channel and what that medium difference enables

This is the fifth episode of Actually ADHD. Earlier episodes covered the optimization blueprint, the medication walkthrough, and the Goldilocks Zone framework. The book The Process: An Adult's Guide to ADHD Medication is available on Amazon: https://www.amazon.com/dp/B0H2Z6PM4T

Find the YouTube channel Focus Path | PMHNP-BC for the full clinical education catalog.

For educational purposes only. Not medical advice. Consult your own provider for clinical decisions.

How to know you're on the correct dose of ADHD medication. Jonathan Murphy, PMHNP-BC, breaks down the Goldilocks Zone — the framework for identifying the right dose of stimulant medication for an adult with ADHD. Not too little, not too much, just right.

This episode covers:

• Why there is no universal "right dose" or "best medication" for ADHD
• The Goldilocks Zone: too low means tired, too high means tweaking out, just right means calm and functional
• Duration as part of the optimization equation and what a crash actually signals
• Why side effects and poor toleration are not necessary parts of ADHD treatment
• The pattern of overstimulation on amphetamines pointing toward methylphenidate
• The pattern of zombification on methylphenidate pointing toward non-stimulants or dexmethylphenidate
• Why extended-release technology is what makes optimization possible at all
• Tonic versus phasic dopamine receptor activation and why consistency is the goal
• The myth of toleration and the normal three-to-four-week adjustment from initial response to maintenance dose
• Why the diagnostic criteria of ADHD are validated by medication response, not just by symptom checklist
• The "prescriber as cop" framing: how the Controlled Substance Act has distorted clinical decision-making
• Why a patient who feels shame at the pharmacy can't ask the simple question "how do I know if I'm on the right dose?"
• The role of secondary symptom resolution — forgetfulness and organizational difficulty as downstream effects of consistent medication
• Why one month is the minimum trial period and what shooting at moving targets looks like
• The internet-filtered version of ADHD: how tribal identity formation distorts clinical reasoning
• Why guanfacine monotherapy in adults is sometimes a signal to reconsider the diagnosis, not to celebrate the medication

This is the fourth episode in the sequence covering the optimization process from the book The Process: An Adult's Guide to ADHD Medication, available on Amazon: https://www.amazon.com/dp/B0H2Z6PM4T

Find the YouTube channel Focus Path | PMHNP-BC for the full clinical education catalog.

For educational purposes only. Not medical advice. Consult your own provider for clinical decisions.

A deep dive into the extended-release ADHD stimulant medications. Jonathan Murphy, PMHNP-BC, walks through every major option in the methylphenidate and amphetamine categories, the clinical reasoning behind choosing one over another, and the specific patient presentations that point toward each medication.

This episode covers:

• The two stimulant categories: methylphenidate and amphetamine
• OROS technology in Concerta versus micro-bead technology in newer extended-release formulations
• Why Concerta's absorption can be spotty and when to move to Ritalin LA
• The methylphenidate bead ratios: 50/50, 60/40, 70/30 and what each one does clinically
• Aptensio, Metadate, and Jornay PM as alternatives within the methylphenidate family
• Focalin (dexmethylphenidate) as the second-line methylphenidate when standard formulations don't deliver
• The amphetamine side: Adderall XR, Vyvanse, Dexedrine, and Mydayis
• Why dextroamphetamine-only options (Vyvanse) work better for some patients than mixed amphetamine salts (Adderall)
• The 25-30% of adult patients who do best on a pure dextroamphetamine
• Why "all good, no bad" is the optimization standard, not "good enough"
• The diagnostic value of medication response: if any properly trialed medication works, the diagnosis is confirmed and other options remain available
• Why FDA-recommended dosing limits are appropriate guardrails, not arbitrary restrictions

This episode references the Top 10 ADHD Stimulants video on the Focus Path YouTube channel: https://youtu.be/xJQLSCGY9Vc

This is the third episode in the sequence covering the optimization process from the book The Process: An Adult's Guide to ADHD Medication, available on Amazon: https://www.amazon.com/dp/B0H2Z6PM4T

Find the YouTube channel Focus Path | PMHNP-BC for the full clinical education catalog.

For educational purposes only. Not medical advice. Consult your own provider for clinical decisions.

The Optimization Blueprint — the algorithm Jonathan Murphy, PMHNP-BC, uses to find the right medication and the right dose for adults with ADHD.

This episode is for two audiences simultaneously: clinicians refining their adult ADHD prescribing practice and patients trying to understand whether their current treatment is optimized.

This episode covers:

• The three medication categories: methylphenidate, amphetamine, and non-stimulant
• Why extended-release stimulants are first-line and why the "controlled substance" framing misleads prescribers
• The standard adult starting doses for the major medications
• The response and toleration framework for assessing the first prescription
• When to start with amphetamine versus methylphenidate based on presentation
• Why methylphenidate is often the better starting point despite being less culturally familiar
• What "optimized" actually means: all good, no bad, no side effects, works like a vitamin
• The risk of dysfunctional medication relationships and how they form
• Why providers who haven't developed comfort with adult ADHD prescribing should consider referring out rather than under-treating

This is the second episode in the sequence covering the optimization process from the book The Process: An Adult's Guide to ADHD Medication, available on Amazon: https://www.amazon.com/dp/B0H2Z6PM4T

Find the YouTube channel Focus Path | PMHNP-BC for the full clinical education catalog.

For educational purposes only. Not medical advice. Consult your own provider for clinical decisions.

The first episode of Actually ADHD.

Jonathan Murphy, PMHNP-BC, board-certified psychiatric nurse practitioner with 20,000+ clinical hours specializing in adult ADHD, opens the show with the conversation the internet hasn't been having.

This episode covers:

• Why the book The Process: An Adult's Guide to ADHD Medication exists and why the field needed it
• The clinical history of ADHD from 18th-century behavioral observations to the modern DSM
• Charles Bradley's 1937 discovery at the Emma Pendleton Bradley Home that changed the field
• The pharmacology evolution from immediate-release amphetamine to modern extended-release formulations
• Why adult ADHD treatment is in some ways newer than the patients in it
• The personal story of becoming the ADHD clinician
• Why most prescribers in primary care and general psychiatry struggle with optimization
• What "Actually ADHD" actually means

The book The Process: An Adult's Guide to ADHD Medication is available on Amazon: https://www.amazon.com/dp/B0H2Z6PM4T

Find the YouTube channel Focus Path | PMHNP-BC for full clinical education content.

For educational purposes only. Not medical advice. Consult your own provider for clinical decisions.